Amgen Net Receivables from 2010 to 2026

AMG Stock  EUR 329.30  11.55  3.63%   
Amgen Net Receivables yearly trend continues to be very stable with very little volatility. Net Receivables is likely to drop to about 5.8 B. During the period from 2010 to 2026, Amgen Net Receivables quarterly data regression pattern had sample variance of 3536868 T and median of  3,580,000,000. View All Fundamentals
 
Net Receivables  
First Reported
2019-03-31
Previous Quarter
8.5 B
Current Value
9.6 B
Quarterly Volatility
1.6 B
 
Covid
 
Interest Hikes
Check Amgen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amgen's main balance sheet or income statement drivers, such as Tax Provision of 1.4 B, Interest Income of 218.9 M or Interest Expense of 1.7 B, as well as many indicators such as . Amgen financial statements analysis is a perfect complement when working with Amgen Valuation or Volatility modules.
  
This module can also supplement various Amgen Technical models . Check out the analysis of Amgen Correlation against competitors.
Evaluating Amgen's Net Receivables across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Amgen Inc's fundamental strength.

Latest Amgen's Net Receivables Growth Pattern

Below is the plot of the Net Receivables of Amgen Inc over the last few years. It is Amgen's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amgen's overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Slightly volatile
   Net Receivables   
       Timeline  

Amgen Net Receivables Regression Statistics

Arithmetic Mean4,554,271,765
Geometric Mean4,261,138,919
Coefficient Of Variation41.29
Mean Deviation1,475,645,813
Median3,580,000,000
Standard Deviation1,880,656,265
Sample Variance3536868T
Range6.4B
R-Value0.83
Mean Square Error1162913.8T
R-Squared0.69
Significance0.000035
Slope309,752,353
Total Sum of Squares56589887.8T

Amgen Net Receivables History

20265.8 B
20259.6 B
20246.8 B
20237.3 B
20225.6 B
20214.9 B
20204.5 B

About Amgen Financial Statements

Amgen investors utilize fundamental indicators, such as Net Receivables, to predict how Amgen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Receivables9.6 B5.8 B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:
Check out the analysis of Amgen Correlation against competitors.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Understanding that Amgen's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Amgen represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Amgen's market price signifies the transaction level at which participants voluntarily complete trades.